Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative or Postoperative Paclitaxel and Carboplatin in Stages IB-IIIA NSCLC
NCT00193310Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Nov 2000
- Primary completion
- Nov 2003
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of paclitaxel, carboplatin in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Nov 2000; status: completed.
02
Drugs
paclitaxelcarboplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00193310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00193310.